![](/img/cover-not-exists.png)
Lenalidomide plus rituximab (R 2 ) in previously untreated marginal zone lymphoma: subgroup analysis and long‐term follow‐up of an open‐label phase 2 trial
Becnel, Melody R., Nastoupil, Loretta J., Samaniego, Felipe, Davis, Richard E., You, M. J., Green, Michael, Hagemeister, Fredrick B., Fanale, Michelle A., Fayad, Luis E., Westin, Jason R., Wang, MichaLanguage:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.15843
Date:
March, 2019
File:
PDF, 267 KB
english, 2019